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Abstract
Background: The development of resistance to antimicrobial therapy by Neisseria gonorrhoeae causes on-going
problems for individual case management of gonorrhoea. Surveillance data about N. gonorrhoeae have indicated
an increase in the incidence of gonorrhoea in France in 2006. As a consequence of the development of antibiotic
resistance in N. gonorrhoeae, French guidelines excluded fluoroquinolones as a standard treatment for N.
gonorrhoeae. Ceftriaxone became the recommended treatment, associated with azithromycin for Clamydia
trachomatis infection. Our aim was to describe the practice patterns of general practitioners (GPs) in managing the
antibiotic treatment of patients with symptoms suggestive of uncomplicated male urethritis.
Methods: We developed a clinical vignette describing a man with typical gonococcal urethritis symptoms to elicit
questions about antibiotic treatment. We mailed the electronic questionnaire to a random sample of 1000 French
GPs belonging to the Sentinelles Network.
Results: By the end of the survey period, 350 vignettes were received, yielding a response rate of 35%. Sixty-six
GPs (20.2%) prescribed the recommended antibiotics for the simultaneous treatment of N. gonorrhoeae and C.
trachomatis infections, while 132 GPs (40.4%) prescribed only non-recommended antibiotics, including ciprofloxacin
in 69 cases (21.1%). General practitioners with less than 10 years in practice showed better compliance to
guidelines than those with more years in practice (p < 0.05).
Conclusions: The results suggest a mismatch between the guidelines and the antibiotic treatment of male
uncomplicated urethritis by French GPs, mostly among the subgroup of physicians who have been in practice
longer. Educational approaches based on practice feedback need to be developed to improve these deficits in the
quality of care.
Background
Over the last few years, the number of gonorrhoea
cases, caused by the gram negative bacterium Neisseria
gonorrhoeae, has continually increased in many Eur-
opean countries, the United States and China [1-3].
However, over the past 60 years N. gonorrhoeae has
developed resistance to multiple classes of antimicro-
bials. Since the first report of tetracycline resistance in
1985, gonococci that are resistant to tetracycline have
spread globally [4]. During a sentinel surveillance study
in Western Europe in 2004, a total of 1055 gonoccocal
isolates were analysed of which 21.3% showed resistance
to penicillin [5]. In addition, high levels of ciprofloxacin-
resistant strains were reported worldwide in the early
1990s [6].
In France, an increase in the incidence of gonorrhoea
cases has been indicated since 1998 [7]. In 2006, the
number of gonorrhoea cases increased by more than
50% compared to 2005. Resistance of N. gonorrhoeae to
ciprofloxacin sharply increased from 0.70% in 1998 to
43% in 2006 [7,8].
An essential element in gonorrhoea control is the
availability and provision of appropriate, effective
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antimicrobial therapy. Effective treatment not only era-
dicates infection in the affected individual and prevents
the development of complications, but it also has an
important public health benefit of decreasing transmis-
sion and eliminating reservoirs of infection. Thus,
improving the appropriateness of antimicrobial use for
the treatment of gonorrhoea is an important goal at
national and international levels. New guidelines ratio-
nalizing antibiotic prescription for the probabilistic
treatment of uncomplicated male urethritis were pub-
lished in France in 2005 by the French Health Products
Safety Agency (Afssaps) [9], recommending ceftriaxone
as the first-line treatment, always associated with azi-
thromycin for Clamydia trachomatis infection. Briefly,
the recommended regimens, for all adult and adolescent
patients, are ceftriaxone (intravenous/intramuscular) or
cefixime (oral dosage) only if injectable is refused or not
possible to do. If the patient is allergic to ceftriaxone
or cefixime an alternative regimen is spectinomycin.
Recommended regimens for C. trachomatis are azytro-
micin or doxycycline. As a consequence of the develop-
ment of antibiotic resistance in N. gonorroheae, new
French guidelines excluded fluoroquinolones as a stan-
dard treatment for N. gonorrhoeae.
General Practitioners (GPs) play an important role in
preventing and treating male gonoccocal urethritis [10].
Consequently, it is worth making sure that GPs have a
good working knowledge of antimicrobial use for gonor-
rhoea treatment. In this study, we conducted a national
cross-sectional study using a clinical vignette to examine
GPs’ antibiotic prescribing in the treatment of gonocco-
cal male urethritis.
Methods
From June 2008 to August 2008, a cross-sectional study
was conducted among GPs belonging to the Sentinelles
Network [11], a computerized disease-surveillance system
with about 1260 active volunteer GPs located throughout
mainland France. The GPs participating in the Sentinelles
Network are representative of the whole French GP
population regarding age, location, type (rural/urban) and
kind of practice (alone/pluridisciplinary) [12].
General practitioners who had previously agreed to
participate at least once in our ad-hoc epidemiological
studies by electronic means (n = 1000) were invited to
complete a questionnaire
In September 2008, after data collection, a sample of
70 randomly selected non-respondent GPs was con-
tacted by e-mail to ascertain the reasons for non-
participation.
The French Sentinelles Network were given ethical
approval (CNIL 471393) for the study. Moreover, the
participation of GPs was voluntary and they could with-
draw at any time. All data were handled confidentially
and the results from the study were presented in a non-
identifiable way.
Survey development
A scientific committee composed of one specialist in
venereal diseases, one epidemiologist, one general inter-
nist and one microbiologist developed a vignette [13,14]
designed to examine current practice patterns in the
antibiotic treatment of uncomplicated male urethritis
using scientific literature and guidelines [9,13,14]. The
vignette was developed using a standardized protocol
[13,14]. This approach has been shown to be an effec-
tive and cost-efficient method for measuring physicians’
clinical decision making [13,14]. A pilot study was con-
ducted with eight volunteer GPs of the Sentinelles Net-
work that validated the vignette.
The scientific committee defined a master criteria list
to review GP responses using scientific literature and
guidelines [9,13-15]. We submitted the candidate criteria
to a panel of 12 academic and community physicians of
various specialities (general practice, infectious diseases,
venereal diseases, microbiologists and public health).
Based on their recommendations and group consensus,
we finalized a master criteria list. Responses were
considered appropriate if the hypothetical patient was
treated simultaneously for N. gonorrhoeae and C. tracho-
matis infections with the following recommended first-
line antibiotics:
a) ceftriaxone (250 to 500 mg intravenously or intra-
muscularly, in a single dose) or cefixime (400 mg
orally in a single dose) or, as an alternative regimen,
spectinomycin (2 g intramuscularly in a single dose)
for N. gonorrhoeae treatment
b) azithromycin (1 g orally in a single dose) or doxy-
cycline (100 mg orally twice a day for 7 days) for C.
trachomatis treatment.
The vignette was submitted to the GPs via a web-
based electronic format (see additional file): the GPs
were asked to write a description of their treatment plan
in an open-ended format. A time constraint of 20 min-
utes was imposed for completing the vignette. After
answering a given section, participants could not return
to the previous section to revise their answers.
After the clinical vignette, a new section measuring
the GPs’ knowledge of French guidelines and of the
increasing resistance to ciprofloxacin for gonorrhoea
treatment through two questions completed the survey:
1. “Are you aware of the increasing rate of ciproflox-
acin resistance for gonorrhoea?”
2. “Are you aware of the existence of the new guide-
lines for the management of urethritis?”
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At the end of the study, each participating GP
received an individual report of his results, the average
performance of the group and the responses to the
vignette.
Statistical analysis
Data were analysed using the R software program
(http://www.r-project.org) using descriptive statistics for
frequencies and chi-square tests for the comparisons of
independent proportions, with Fisher’s tests where
appropriate. The level of significance was set as p < 0.05.
The GPs’ answers were reviewed by two independent
reviewers. An inter-rater reliability analysis using the
Kappa statistic was performed to determine consistency
among the raters [16]. The inter-rater reliability for the
raters was found to be Kappa = 0.83 (p < 0.001), sug-
gesting a very good agreement.
Results
Sample
By the end of the survey period, 350 vignettes were
received, yielding a response rate of 35%. The vignette
was fully completed by 327 GPs (93.4%).
The responders were predominantly male (83.4%) with
a mean age of 52 ± 7.5 years (min = 29; max = 69).
Their practices were mainly located in urban zones
(60%) (Table 1).
Demographic characteristics (age, sex and location) of
the GP responders, non-responders and of the GPs of
the Sentinelles Network are shown in Table 1.
Among the 70 non-responding GPs, 67% (n = 47)
declared that they had no experience of urethritis man-
agement in their practice, 26% (n = 18) did not partici-
pate because of a lack of time and 7% (n = 5) did not
participate for other several reasons (e.g. holidays, the
survey was too complex or they were not interested.
Antimicrobial agents used
Sixty-six GPs (20.2%) prescribed the simultaneous
administration of the recommended antibiotics for N.
gonorrhoeae and C. trachomatis infections (Table 2) for
the hypothetical patient.
One hundred and fourteen (34.8%) GPs prescribed
only one recommended antibiotic against N. gonor-
rhoeae (n = 69) or against C. trachomatis (n = 45). One
hundred and thirty-two GPs (40.4%) prescribed only
non-recommended antibiotics, including ciprofloxacin,
in 69 cases (Table 2).
Knowledge of fluoroquinolone resistance emergence and
the treatment guidelines
When asked about the fluoroquinolone resistance of N.
gonorrheoae, 26% (n = 84) of the respondents declared
that they were aware of the high rate of resistance in
France. The existence of the French guidelines was
declared known by 25% (n = 81) of GPs. Among the 69
GPs who prescribed ciprofloxacin as first-line treatment,
84% (n = 58) were not aware of the emergence of fluor-
oquinolone resistance.
Influence of prescriber factors
General practitioners who had been in practice for
10 years or less were more likely to prescribe the recom-
mended antibiotics than GPs with more years in practice
(p < 0.0001; Table 3). General practitioners who had
been in practice for 10 years or less were also more likely
to be aware of the high rate of fluoroquinolone resistance
and of the existence of guidelines (p < 0.0001; Table 3).
Gender and geographic location (urban, suburban or
Table 1 Demographic characteristics of GP respondents, non-respondents and GPs of the Sentinelles Network
Demographic characteristics GP respondents
No = 350
GP non respondents
No = 650
GPs of the Sentinelles
Network No = 1260
p value
Sex (male) % 83.4% 82% 82% 0.97
Age (years), mean ± SD 52 ± 7.5 52.3 ± 7.6 52.8 ± 7.8 0.96
Practice location,%
Urban 60% 61% 62% 0.96
Sub-Urban 19% 16% 18% 0.96
Rural 21% 19% 20% 0.94
Table 2 Antibiotic treatments prescribed by the GPs
Treatments prescribed Respondents No. (%)
No = 327 (%)
Two recommended antibiotics* 66 (20.2)
One recommended antibiotic 114 (34.8)
against N. gonorrhoeae Ψ 69 (21.1)
against C. trachomatis ΨΨ 45 (13.7)
One non-recommended antibiotic 147 (45)
Ciprofloxacin 69 (21.1)
Amoxicillin 24 (7.3)
Others 54 (16.6)
*for N. gonorrhoeae and C. trachomatis co-infections
Ψ Ceftriaxone or spectinomycin or cefixime
ΨΨ Azithromycin or doxycycline
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rural) of the GP was not associated with the treatments
prescribed or knowledge of the guidelines (p > 0.05).
Discussion
Summary of the main findings
In this study, only a minority of the GPs (20.2%) correctly
co-prescribed the first-line treatment recommended for
N. gonorrhoeae and C. trachomatis co-infection. More-
over, the GPs frequently prescribed non-recommended
first-line treatment, including ciprofloxacin, despite the
high level of fluoroquinolone resistance of N. gonorrhoeae
in France (43% during 2006) [7,8].
The relatively low level of prescribed treatment against
C. trachomatis could be explained by the description of
the purulent discharge of the urethritis in the vignette,
which is a typical sign of N. gonorrhoeae infection. These
results are in agreement with a previous study on the
compliance of emergency department practitioners with
the Centers for Disease Control (CDC) recommendations
for diagnosing and treating sexually transmitted diseases.
This study showed that the recommended antibiotic regi-
mens for N. gonorrhoeae and C. trachomatis were cor-
rectly co-prescribed in only one third of cases [17].
In this study, GPs who had been in practice for
10 years or less were more likely to prescribe first-line
treatment in accordance with the guidelines and they
were better informed about the increasing rate of fluor-
oquinolone resistance and about the new national strat-
egy for the therapeutic management of probabilistic
treatment for uncomplicated male urethritis than physi-
cians who had been in practice longer.
The results suggested that the overall rate of compli-
ance with national guidelines concerning antibiotic
choice must be improved among GPs. In particular, the
subgroups of physicians who have been in practice for
longer are at risk of providing lower-quality care.
These findings are consistent with other studies that
suggested an inverse relationship between years in
practice and the quality of care provided [18,19]. A sys-
tematic review which evaluated the relationship between
clinical experience and performance suggested that phy-
sicians who have been in practice for a longer period
and those who are older possess less factual knowledge,
are less likely to adhere to appropriate standards of care,
and may also have poorer patient outcomes. These
effects seemed to persist in studies that adjusted for
other known predictors of quality, such as patient
comorbidity and physician volume or specialization [18].
As observed in this study, barriers to guideline adher-
ence, such as a lack of agreement and a lack of familiar-
ity, seem improbable in the case of urethritis, for which
the recent guidelines are easily justified (a high rate of
quinolone resistance) and quite straightforward to apply
(a simple antibiotic prescription) [7-9]. One reason for
the clinicians prescribing contrary to the guidelines is
most probably unawareness of the guidelines. The fact
that an increasing number of years in practice is asso-
ciated with prescribing non-recommended antibiotics
favours this hypothesis, although we cannot exclude
other reasons. For example, GPs may find that prescrib-
ing an intramuscular treatment such as ceftriaxone
might create a barrier because the patient has to buy
the injectable drug and then go back to the GP to be
injected with it. Another possible reason for little knowl-
edge of the guidelines could be due to the volume of
biomedical information available and the time needed to
learn about new developments. The guidelines rationa-
lizing antibiotic prescription for the probabilistic treat-
ment of uncomplicated male urethritis were published
in France in 2005 and disseminated to GPs at the
national level by Afssaps [9], preferably by electronic
means (mailing lists and publication on health websites).
The fact that the recommendations were preferentially
disseminated using electronic sources, of which younger
GPs are greater users than older practitioners, could
have added another barrier against compliance with the
Table 3 Association between years in practice and the physicians’ practice patterns in managing gonoccocal urethritis
treatment and their knowledge of fluoroquinolone resistance emergence and of the guidelines
Years of practice ≤10 years
No. (%)
11-20 years
No. (%)
>20years
No. (%)
p value
First-line treatment
One recommended antibiotic against N. gonorrhoeae¥ 18 (36) 22 (28) 29 (15) 0.0012
One recommended antibiotic against C. trachomatis ΨΨ 12 (42) 19 (24) 14 (2.5) 0.0002
Two antibiotics prescribed concomitantly* 20 (40) 26 (32) 20 (10) <0.0001
Knowledge of fluoroquinolone resistance emergence and guidelines
Awareness of the existence of the French guidelines 22 (44) 26 (32.5) 33 (16.8) <0.0001
Awareness of fluoroquinolone resistance 28 (56) 24 (30) 32 (16) <0.0001
*for N. gonorrhoeae and C. trachomatis co-infection
Ψ Ceftriaxone or spectinomycin or cefixime
ΨΨ Azithromycin or doxycycline
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recommendations. It must be noted that, according to a
survey by the Centers for Disease Control and Preven-
tion’s National Center for Health Statistics [20], it seems
that a majority of office-based physicians use electronic
medical record (EMRs) systems. A 2010 report by the
Centers for Disease Control and Prevention’s National
Center for Health Statistics [20] reported that the
younger the doctor, the more likely he or she was to
embrace electronic medical records (EMRs), although
the resistance to them by older physicians seems to
have decreased as EMRs have become more common in
offices and hospitals.
Limitations of the study
There were several limitations to this study. The first was
that we used a self-reported survey to measure compli-
ance with guideline recommendations as it is possible
that physicians answered questions in ways that reflected
professional desirability rather than their own practices.
The second limitation of this study was that we only pro-
posed one scenario that did not cover the full clinical
presentation of urethritis. However, the principal objec-
tive was to evaluate the application of guideline recom-
mendations for the management and treatment of male
uncomplicated urethritis, mostly due to gonorrhoea.
Thirdly, there may have been limitations in generalizabil-
ity to the French GP population, as reflected by the
response rate of 35%. Moreover, the GPs who partici-
pated in this study were more concerned about urethritis
than non-responders, as shown by the non-responders’
answers, and therefore their practices might differ. How-
ever, we found no differences in the demographic data
between responders and non-responders regarding age,
gender, and location of the practice.
Conclusions
Implications for clinical practice and future research
This study suggests that interventions to improve physi-
cians’ knowledge about the management of public health
issues are warranted, especially regarding the subgroup of
physicians who have been in practice the longest. More-
over, because drug-resistant N. gonorrhoeae is becoming
an increasing problem worldwide, such an evaluation of
treatment practices would probably be useful in other
countries.
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